Inside the research

ResMed Inc.

RMD Research profile · latest available data

Price overview

$222.00

▲ +0.11 (+0.0%)

52w hi$280.31
52w lo$182.30
Vol760.80K
As of25 Sep 2026

The Verdict

Hold

Our score +0.19

Short+0.01
Medium+0.29
Long+0.33

computed 2026-09-27

Key fundamentals

ResMed Inc.

Healthcare · Medical Instruments & Supplies

Market cap$32.02B
Enterprise value$31.38B
Trailing P/E21.28x
Forward P/E16.78x
EV / EBITDA14.97x
P / S (ttm)5.66x
Profit margin26.9%
Return on equity24.3%
Revenue growth+8.6%
Earnings growth+2.4%
Debt / equity12.54

Layer Breakdown

LayerRawContribution
Fundamental+0.26
Sector+0.08
Technical+0.04
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

United States · www.resmed.com

Risk Metrics

Beta vs SPX0.59
Corr SPX0.33
Annual vol28.2%
Annual ret-0.9%
Sharpe-0.03
Max DD-37.8%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$270.60
High / Low$340.00 / $180.00
Median$286.00
Analysts15
Strong Buy3
Buy8
Hold7
Sell1
Strong Sell0

Recent rating actions

2026-05-01Wells Fargo→ Equal-Weight
2026-05-01RBC Capital→ Outperform
2026-04-27Keybanc→ Overweight
2026-04-09Citigroup→ Buy
2026-02-02Citigroup→ Buy
2026-01-30Wells Fargo→ Equal-Weight

Material Events

DateEvent8-K
2026-08-06Earnings Release, Other Material Event…read
2026-07-07Earnings Release, Reg FD Disclosure…read
2026-04-30Officer / Director Change, Exhibitsread
2026-04-30Earnings Release, Other Material Event…read
2026-01-29Earnings Release, Other Material Event…read
2025-11-20Officer / Director Change, Shareholder Vote…read
2025-10-30Earnings Release, Other Material Event…read
2025-08-18Officer / Director Change, Exhibitsread
2025-08-01Officer / Director Changeread
2025-07-31Earnings Release, Other Material Event…read
2025-04-23Earnings Release, Other Material Event…read
2025-01-30Earnings Release, Other Material Event…read

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-07Farrell Michael J.Chairman and CEOOption exercise4.99K$730.38K
2026-08-07Farrell Michael J.Chairman and CEOSell4.99K$1.03M
2026-08-05FARRELL PETER CSell8.00K$1.80M
2026-07-07Farrell Michael J.Chairman and CEOOption exercise4.99K$730.38K
2026-07-07Farrell Michael J.Chairman and CEOSell4.99K$1.09M
2026-06-08Farrell Michael J.Chairman and CEOOption exercise4.99K$730.38K
2026-06-08Farrell Michael J.Chairman and CEOSell4.99K$968.06K
2026-06-01Rider Michael JGlobal General CounselWithheld for tax269$51.21K
2026-05-07Farrell Michael J.Chairman and CEOOption exercise4.99K$730.38K
2026-05-07Farrell Michael J.Chairman and CEOSell4.99K$1.04M

Flow & Concentration

Insider 180d net-$7.72M
Insider buys / sells0 / 8
Insider biasSellers
13F holders9
Top-5 share97.1%
HHI4,747 (concentrated)

Top Holders

HolderValueShares
State Street Corp$1.30B6.68M
Capital Research / Capital World$251.53M1.29M
AQR Capital Management$177.14M910.62K
Citadel Advisors$118.97M610.48K
Millennium Management$46.17M236.93K
Fidelity / FMR LLC$42.22M216.63K
Bridgewater Associates$13.13M67.38K
Renaissance Technologies$315.71K1.62K
T. Rowe Price Group$72.43K371.66K

As of 2026-06-30

Dividends

Yield (TTM)0.54%
$ / share (TTM)$1.20
5y CAGR+7.7%

Annual dividend per share

2021$1.62
2022$1.72
2023$1.84
2024$2.02
2025$2.26
2026$0.60

SEC Filings

DateFormDoc
2026-08-1310-Kview
2026-08-114view
2026-08-068-Kview
2026-08-064view
2026-07-094view
2026-07-078-Kview
2026-06-094view
2026-06-034view
2026-05-114view
2026-05-043view
2026-05-044view
2026-05-0110-Qview
2026-04-308-Kview
2026-04-308-Kview
2026-04-094view

The Long Run

FY 2011–2025 · 15 years

LineLatestCAGRTrend
Revenue$5.15B+10.7%
Gross profit$2.36B+9.6%
Operating income$1.32B+14.8%
Net income$1.02B+12.8%
Cash from ops$1.40B+19.4%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$221.08$223.22$220.13$222.00760.80K
Sep 24$223.08$224.50$220.39$221.89798.80K
Sep 23$222.78$225.10$220.00$222.301.44M
Sep 22$226.22$227.90$221.82$221.971.03M
Sep 21$225.16$226.52$223.34$223.611.07M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →